ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1922

Insights into Rheumatology Practice in Uganda

Marwin Groener1, Evelyn Hsieh2, Lillian Tugume3 and Mark Kaddumukasa3, 1Johns Hopkins Hospital, Baltimore, MD, 2Yale School of Medicine / VA Connecticut Healthcare System, West Haven, Connecticut, New Haven, CT, 3Makerere University Kampala, Kampala, Uganda

Meeting: ACR Convergence 2024

Keywords: Access to care, Health Care, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Healthcare Disparities in Rheumatology Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Data regarding the prevalence of rheumatic diseases in sub-Saharan Africa is scarce and only a small number of rheumatologists practice in this region. Uganda with its 48 million people has two practicing rheumatologists, both working in the capital city of Kampala. The goal of this project was to describe the local spectrum of rheumatic diseases, available testing, medications, costs, and unique challenges.

Methods: From January-February 2024, de-identified clinic-level data regarding types of referrals and diagnoses encountered at the weekly Rheumatology Clinic at Mulago National Referral Hospital in Kampala, Uganda was aggregated over a six-week period. Pricing for laboratory tests and medications was obtained from a local laboratory and three local pharmacies.

Results: The most common conditions presenting at the Rheumatology Clinic included rheumatoid arthritis, osteoarthritis, connective tissue diseases, including systemic lupus erythematosus and systemic sclerosis, fibromyalgia, and unclear diagnoses. Knowledge gaps among primary care doctors lead to a high number of referrals for osteoarthritis. The available diagnostic testing includes anti-nuclear antibodies, disease-specific autoantibodies such as rheumatoid factor, anti-cyclic citrullinated peptide antibodies, anti-double stranded DNA antibodies, anti-neutrophil cytoplasmic antibodies, CRP, and complement levels. Laboratory testing is mainly provided by private laboratories and is usually paid out-of-pocket. Test prices range from USD 3.35 to USD 33.25, thereby exceeding multiple times the median daily income of USD 2.50. Prednisolone and oral disease-modifying anti-rheumatic drugs (DMARDs) such as azathioprine, methotrexate, hydroxychloroquine, and tofacitinib are frequently prescribed. Average monthly drug prices range from USD 3.12 to USD 65.52. Some biologics including rituximab and adalimumab are available, however, are usually not affordable for patients. The easy availability of glucocorticoids over-the-counter complicates the management of steroid tapers. Cost and the reportedly high rate of latent tuberculosis in the population limit the use of TNF-alpha inhibitors.

Conclusion: Access to rheumatology care in Uganda is constrained by a paucity of rheumatologists. The spectrum of available laboratory testing is extensive. Oral DMARDs are the mainstay of therapy, whereas biologics are not regularly used. Costs are a strong limiting factor for both diagnostics and medications. Research is needed to determine the prevalence of rheumatic diseases in Uganda. Additionally, the education of more providers in the diagnosis and management of rheumatic and musculoskeletal conditions is paramount to meet the needs of a growing population. This emphasizes the necessity for enhanced training opportunities for local physicians.


Disclosures: M. Groener: None; E. Hsieh: None; L. Tugume: None; M. Kaddumukasa: None.

To cite this abstract in AMA style:

Groener M, Hsieh E, Tugume L, Kaddumukasa M. Insights into Rheumatology Practice in Uganda [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/insights-into-rheumatology-practice-in-uganda/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/insights-into-rheumatology-practice-in-uganda/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology